Stock Updates

AbbVie Inc. (NYSE: ABBV) – Is this large market cap stock undervalued?

AbbVie Inc. (NYSE: ABBV), is firmly in the large market cap category with market cap of 99524.4. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for AbbVie Inc. is 61.14 (with a change from open of 0.30%), this in conjunction with a target price of 71.28. Volume today has so far reached 2910739, with an average volume of about 6423.47. The GAP for this stock, is -0.41%.

The P/E ratio is 17.55, bringing the forward P/E to a value of 10.84. The current EPS for AbbVie Inc., is 3.49, with a EPS growth for this year coming to a value of 185.20%. Performance has been interesting with performance year to date coming to 7.32%.

Looking further into the growth statistics for AbbVie Inc., EPS is looking like it will grow 17.40% in the next year. Looking even further it is projected to be 16.25%. Quarter over quarter is 17.90% for EPS growth and for sales growth quarter over quarter it is 17.80%. Looking at past EPS growth statistics we see that for the past five years it has been 3.50%. Sales growth for the past five years has in fact been 7.90%.

Looking at the ownership, we see that the insider ownership is at 0.10% and institutional ownership is 70.20%. Shares outstanding is 1625.95, while shares float is at a value of 1625.95. Float short for AbbVie Inc. is 2.32% and the short ratio is 5.88.

In terms of debt, long term debt/equity is 6.62, while the total debt/equity comes to 6.71. The ability to meet these debts, means that the current ratio is 1.8, and the quick ratio is 1.6. The most recent gross margin is 78.60% and their operating margin is 35.00%. The profit margin is 23.10%.

AbbVie Inc. has seen returns on assets of 10.00%, and on investment, 16.90%. Return on equity is 119.80%. Price/Earnings to growth ratio is 1.08. Price/Sales ratio is at a value of 4.02, with Price/book ratio coming to 17.64 and Price/cash is 12.44, and finally Price/Free cash Flow is 24.28.

The simple moving averages are -4.56% and 2.74% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -9.42% and the 52 week low is 39.72%.

AbbVie Inc. has a dividend yield of 3.72%, with a current price of 61.14. The ability to pay this means the payout ratio is 63.30%. This is in an industry, Drug Manufacturers – Major, with equally high dividends from other companies in this sector, which it is Healthcare. AbbVie Inc. is based in USA.

Performance in the Drug Manufacturers – Major industry means that AbbVie Inc. has seen performance for the past week of -2.55%, with performance for the month coming to -2.47%. Looking at the data for the quarter it is at a value of -2.90%, and for the half year the performance is 18.17%. Volatility for this week is 1.58% and for the month this is 1.50%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment